AFFINIMARK TECHNOLOGIES INC

Profile

Company Names

AFFINIMARK TECHNOLOGIES INC

Addresses

300 GEORGE STREET, SUITE 561, NEW HAVEN, CT 06511

Phone Numbers

203-676-3676

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$2,371,894.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2016-02-12 
$1,550,000.00 
$1,550,000.00 
$0.00 
Debt 
1
2010-09-27 
$821,894.00 
$1,359,394.00 
$537,500.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KEVIN 
 
CROWLEY 
DIRECTOR
AFFINIMARK TECHNOLOGIES INC   |  OIL PURIFICATIONS SYSTEMS INC   |  INTELLIGENT CLEARING NETWORK INC   |  SOLAIS LIGHTING INC   |  RAPID OXYGEN CO   |  CONVEXITY SCIENTIFIC INC.   |  TORIGEN PHARMACEUTICALS, INC.   |  PEROSPHERE TECHNOLOGIES INC.
LARRY 
 
DILLAHA 
EXECUTIVE OFFICER
INVASC THERAPEUTICS, INC.   |  INSYS THERAPEUTICS, INC.   |  NEW HAVEN PHARMACEUTICALS, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  MELT PHARMACEUTICALS, INC.
KONSTANTINE 
 
DRAKONAKIS 
DIRECTOR
CARDIOPHOTONICS LLC   |  TWIGTEK, INC   |  EPIEP, INC.   |  CMDBIOSCIENCE,INC.   |  SOFT TISSUE REGENERATION, INC.   |  AMASTAN TECHNOLOGIES LLC   |  AFFINIMARK TECHNOLOGIES INC   |  TEARSOLUTIONS, INC.   |  BIOREZ, INC.   |  6K INC.   |  NIMBUS POWER SYSTEMS, INC.
PATRICK 
 
FOURTEAU 
EXECUTIVE OFFICER
INSYS THERAPEUTICS, INC.   |  NEW HAVEN PHARMACEUTICALS, INC.   |  AFFINIMARK TECHNOLOGIES INC
MICHAEL 
 
MILLIGAN 
EXECUTIVE OFFICER
CONFORMIS INC   |  HIGHRES BIOSOLUTIONS, INC.   |  DECISYON, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  WALK2TOWN HOLDINGS, LLC
HARRY 
H 
PENNER JR 
EXECUTIVE OFFICER, DIRECTOR
AFFINIMARK TECHNOLOGIES INC
HARRY 
H. 
PENNER, JR. 
EXECUTIVE OFFICER, DIRECTOR
MARINUS PHARMACEUTICALS INC   |  RIB X PHARMACEUTICALS INC   |  RIB-X PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.   |  AFFINIMARK TECHNOLOGIES INC   |  NEW HAVEN PHARMACEUTICALS, INC.   |  CELLDEX THERAPEUTICS, INC.
VINCENT 
 
PIERIBONE 
DIRECTOR, EXECUTIVE OFFICER
AFFINIMARK TECHNOLOGIES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-03-03
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-12 
2016-03-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-12 
2010-10-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#